Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Ace Inhibitors Prevent Sudden Cardiac Death Posted: Tuesday, September 21, 2004

An ace inhibitor showed a 21% reduction in unexpected deaths, deaths due to cardiac arrest, or nonfatal cardiac arrest. Past studies have shown that these medications reduce the risk of heart attack and stroke in people with heart disease. Now comes word that they can also dramatically lower the risk of sudden cardiac death and nonfatal cardiac arrest in people at high risk.

Cholesterol Drugs Lower Glaucoma Risk Posted: Monday, September 20, 2004

Researchers found a 40 percent decrease in glaucoma among long-term statin users". So there are a couple of good reasons to suspect that statins might actually be protective for patients against developing glaucoma, or perhaps in the future against the worsening of glaucoma if someone has already developed it."

Exenatide New Drug Application Accepted by the FDA Posted: Thursday, September 16, 2004

First potential therapy in a new class of drugs under investigation for the treatment of type 2 diabetes known as incretin mimetics. Lilly and Company announced that the New Drug Application (NDA) for exenatide has been accepted for review by the Food and Drug Administration (FDA).

Help Is On The Way For Losing Weight And Smoking Cessation Posted: Thursday, September 16, 2004

First year results of the two year trial Rimonabant In Obesity (RIO, a Phase III clinical study), showed a 3.5 inch reduction in waist circumference, 19 pounds lost, reduced metabolic syndrome 50%, raised HDL 28%. Rimonabant (endocannabinoid) in another study doubled the odds of quitting smoking without weight gain

Help Is On The Way For Losing Weight And Smoking Cessation Posted: Thursday, September 16, 2004

First year results of the two year trial Rimonabant In Obesity (RIO, a Phase III clinical study), showed a 3.5 inch reduction in waist circumference, 19 pounds lost, reduced metabolic syndrome 50%, raised HDL 28%. Rimonabant (endocannabinoid) in another study doubled the odds of quitting smoking without weight gain

FDA Approves OptiClik(TM), New Insulin Pen System from Aventis Posted: Thursday, August 19, 2004

Precision delivery device offers an additional tool to help people with diabetes achieve their treatment targets with once-daily LANTUS®

New National Cholesterol Education Program (NCEP) Guidelines Call For LDL Levels Of Below 70 Posted: Monday, July 19, 2004

The National Cholesterol Education Program (NCEP) has updated their Adult Treatment Panel (ATP) III guidelines with evidence derived from recent statin trials. The updated recommendations, which are endorsed by The National Heart, Lung, and Blood Institute, the American College of Cardiology, and the American Heart Association, suggest that more intensive cholesterol treatment is an option for people at high risk for myocardial infarction (MI) and cardiovascular death. recent statin trials

Women Not Using Heart-Protecting Aspirin As Men Are Posted: Wednesday, June 30, 2004

An aspirin a day may help keep a heart attack away, but many women at risk for heart disease still don't take one, a new study finds. Men, by comparison, are more likely to pop aspirin regularly — but less likely than women to remember or follow advice about diet and exercise habits that can help their hearts

Women Not Using Heart-Protecting Aspirin As Men Are Posted: Wednesday, June 30, 2004

An aspirin a day may help keep a heart attack away, but many women at risk for heart disease still don't take one, a new study finds. Men, by comparison, are more likely to pop aspirin regularly — but less likely than women to remember or follow advice about diet and exercise habits that can help their hearts

ADA Guidelines Recommend Statins for Most Diabetics Posted: Thursday, June 10, 2004

Almost everyone with diabetes should consider taking a statin drug to lower cholesterol, even if they already have low cholesterol levels. Diabetics should also consider taking a daily aspirin, too, the new guidelines stated.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.